佰仁医疗跌2.12%，成交额1616.13万元，主力资金净流出94.71万元

Core Insights - The stock price of Baijun Medical experienced a decline of 2.12% on November 4, reaching 110.60 CNY per share, with a total market capitalization of 15.235 billion CNY [1] - The company has seen a year-to-date stock price increase of 2.21%, with a 5-day increase of 0.55% and a 20-day increase of 5.35%, while experiencing a 60-day decline of 4.65% [1] Financial Performance - For the period from January to September 2025, Baijun Medical reported a revenue of 382 million CNY, reflecting a year-on-year growth of 30.58%, and a net profit attributable to shareholders of 92.697 million CNY, which is a 57.93% increase year-on-year [2] - Cumulative cash dividends since the company's A-share listing amount to 374 million CNY, with 287 million CNY distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 15.65% to 3,962, while the average circulating shares per person decreased by 13.31% to 34,767 shares [2] - Among the top ten circulating shareholders, notable changes include an increase in holdings by China Europe Times Pioneer Stock A and the entry of Yuanxin Yongfeng Ju You A as a new shareholder [3]